ÂÜÀòÂÒÂ×

Cheryl Byun, PharmD, currently serves as the Sr. Director of Regulatory Affairs Labeling and Promotions at Atara Biotherapeutics since June 2021, after holding the position of Director of Regulatory Affairs Labeling. Prior experience includes serving as Director of Regulatory Labeling at Intercept Pharmaceuticals and a significant tenure at Amgen from April 2006 to March 2020, where roles included Compliance Policies Lead and Global Labeling Lead. Cheryl also held positions at Bristol-Myers Squibb and Johnson & Johnson early in the career. Cheryl Byun earned a Doctor of Pharmacy degree from Rutgers University between 1998 and 2004.